<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="372098">
  <stage>Registered</stage>
  <submitdate>9/01/2017</submitdate>
  <approvaldate>11/01/2017</approvaldate>
  <actrnumber>ACTRN12617000051347</actrnumber>
  <trial_identification>
    <studytitle>Haemoglobinopathy Registry </studytitle>
    <scientifictitle>Haemoglobinopathy Registry </scientifictitle>
    <utrn />
    <trialacronym>HbR</trialacronym>
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Thalassaemia</healthcondition>
    <healthcondition>Sickle cell disease</healthcondition>
    <conditioncode>
      <conditioncode1>Blood </conditioncode1>
      <conditioncode2>Other blood disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>This is a patient Registry collecting information on patients with a diagnosis of sickle cell disease, alpha-thalassemia, beta-thalassemia and other haemoglobinopathies. Information will be collected by review of medical records  for a period of five years.</interventions>
    <comparator>No control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Survival assessed by review of hospital medical records</outcome>
      <timepoint>five years</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Variation in treatment assessed by hospital records</outcome>
      <timepoint>five years</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients with a diagnosis of sickle cell disease, alpha-thalassemia, beta-thalassemia and other haemoglobinopathies.</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>patients who have chosen to opt-off the registry.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods>A detailed pre-determined statistical plan will be developed prior to planned analyses of registry data.

Analysis plans will be reviewed by the Steering Committee and by a suitably qualified statistician prior to data from the Haemoglobinopathy Registry being analysed.</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>True</patientregistry>
    <followup>5</followup>
    <followuptype>Years</followuptype>
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Convenience sample</selection>
    <timing>Both</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate />
    <actualstartdate>6/01/2014</actualstartdate>
    <anticipatedenddate>31/12/2022</anticipatedenddate>
    <actualenddate />
    <samplesize>500</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>31/12/2022</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW,WA,VIC</recruitmentstate>
    <hospital>Monash Medical Centre - Clayton campus - Clayton</hospital>
    <hospital>The Royal Childrens Hospital - Parkville</hospital>
    <hospital>Royal Prince Alfred Hospital - Camperdown</hospital>
    <hospital>The Children's Hospital at Westmead - Westmead</hospital>
    <hospital>Lady Cilento Children's Hospital - South Brisbane</hospital>
    <hospital>Sir Charles Gairdner Hospital - Nedlands</hospital>
    <hospital>Princess Margaret Hospital - Subiaco</hospital>
    <hospital>The Royal Adelaide Hospital - Adelaide</hospital>
    <hospital>Prince of Wales Hospital - Randwick</hospital>
    <hospital>Womens and Childrens Hospital - North Adelaide</hospital>
    <postcode>3168 - Clayton</postcode>
    <postcode>3052 - Parkville</postcode>
    <postcode>2050 - Camperdown</postcode>
    <postcode>2145 - Westmead</postcode>
    <postcode>4101 - South Brisbane</postcode>
    <postcode>6009 - Nedlands</postcode>
    <postcode>6008 - Subiaco</postcode>
    <postcode>5000 - Adelaide</postcode>
    <postcode>2031 - Randwick</postcode>
    <postcode>5006 - North Adelaide</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Monash University</primarysponsorname>
    <primarysponsoraddress>Wellington Road
Clayton, Victoria, 3800</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Celgene Pty Limited</fundingname>
      <fundingaddress>level 7 607 St Kilda Road
Melbourne Victoria 3004</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of this study is to provide long-term patient follow-up and review of clinical and correlative data outside of clinical trials.

Who is it for?
The registry will collect information on patients with a diagnosis of sickle cell disease, alpha-thalassemia, beta-thalassemia and other haemoglobinopathies.

Study Details
Treating clinicians at sites will identify patients and enrol them to the study. The following categories of data items will be collected to the Haemoglobinopathy database using a web portal:
Demographic details
Clinical presentation
Laboratory results
Therapy
Complications (of therapy or condition) 
Outcomes

It is hoped that the findings from this study will identify patterns of treatment and variation in outcomes, for survival and quality of life. Findings will be valuable in informing optimal treatment strategies.
</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Monash Health HREC</ethicname>
      <ethicaddress>Monash Medical Centre
246 Clayton Road
Clayton, Victoria, 3168</ethicaddress>
      <ethicapprovaldate>19/12/2013</ethicapprovaldate>
      <hrec>Monash Health HREC Ref: 13372A</hrec>
      <ethicsubmitdate>7/11/2013</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Royal Children's Hospital HREC</ethicname>
      <ethicaddress>50 Flemington Road 
Parkville Victoria 3052</ethicaddress>
      <ethicapprovaldate>19/12/2014</ethicapprovaldate>
      <hrec>34123 A</hrec>
      <ethicsubmitdate>29/05/2014</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Princess Margaret Hospital HREC</ethicname>
      <ethicaddress>Roberts Rd, 
Subiaco WA 6008</ethicaddress>
      <ethicapprovaldate>10/08/2016</ethicapprovaldate>
      <hrec>2016095EP</hrec>
      <ethicsubmitdate>21/07/2016</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Royal Prince Alfred Hospital HREC</ethicname>
      <ethicaddress>Missenden Rd, 
Camperdown NSW 2050</ethicaddress>
      <ethicapprovaldate>25/06/2014</ethicapprovaldate>
      <hrec>HREC/13/RPAH/527</hrec>
      <ethicsubmitdate>13/11/2013</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Erica Wood</name>
      <address>Monash University
Department of Epidemiology and Preventive Medicine
The Alfred Centre
99 Commercial Road
Melbourne, VIC 3004</address>
      <phone>+61 3 99030051</phone>
      <fax />
      <email>erica.wood@monash.edu</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Zoe McQuilten</name>
      <address>Monash University
Department of Epidemiology and Preventive Medicine
The Alfred Centre
99 Commercial Road
Melbourne, VIC 3004</address>
      <phone>+61 3 99030379</phone>
      <fax />
      <email>zoe.mcquilten@monash.edu</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Zoe McQuilten</name>
      <address>Monash University
Department of Epidemiology and Preventive Medicine
The Alfred Centre
99 Commercial Road
Melbourne, VIC 3004</address>
      <phone>+61 3 99030379</phone>
      <fax />
      <email>zoe.mcquilten@monash.edu</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Neil Waters</name>
      <address>Monash University
Department of Epidemiology and Preventive Medicine
The Alfred Centre
99 Commercial Road
Melbourne, VIC 3004</address>
      <phone>+61 3 99030407</phone>
      <fax />
      <email>neil.waters@monash.edu</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>